Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2002 October;54(5) > Minerva Pediatrica 2002 October;54(5):365-72

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints

 

REVIEWS   

Minerva Pediatrica 2002 October;54(5):365-72

Copyright © 2002 EDIZIONI MINERVA MEDICA

language: English

Growth hormone treatment in children with cystic fibrosis

Hardin D. S.


PDF


Children with cystic fibrosis (CF) have problems with poor linear growth and inadequate weight gain. Nutritional augmentation has been the mainstay of therapy for improving both weight and height in CF; however inadequate growth continues to be a problem. Furthermore, protein catabolism has been documented even in non-acutely ill adults and children with CF, and could adversely affect longitudinal growth. Human recombinant growth hormone (GH) has positive effects on nitrogen balance, and multiple studies have demonstrated improved height and weight in children treated with GH. The purpose of this article is to summarize studies evaluating GH use in children with CF.

top of page